Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,752,000 | 4,477,000 | 12,027,000 | 7,023,000 | 5,583,000 |
| Receivables | 8,953,000 | 8,945,000 | 6,365,000 | 6,280,000 | 6,337,000 |
| Inventories | 5,483,000 | 5,051,000 | 4,906,000 | 4,625,000 | 4,342,000 |
| Other current assets | 1,588,000 | 1,640,000 | 1,426,000 | 1,332,000 | 1,423,000 |
| TOTAL | $18,776,000 | $20,113,000 | $24,724,000 | $19,260,000 | $17,685,000 |
| Non-Current Assets | |||||
| PPE Net | 8,448,000 | 8,333,000 | 7,049,000 | 6,560,000 | 6,133,000 |
| Intangibles | 61,099,000 | 62,037,000 | 38,836,000 | 39,294,000 | 39,654,000 |
| Other Non-Current Assets | 4,424,000 | 4,640,000 | 2,991,000 | 2,584,000 | 2,459,000 |
| TOTAL | $73,971,000 | $75,010,000 | $48,876,000 | $48,438,000 | $48,246,000 |
| Total Assets | $92,747,000 | $95,123,000 | $73,600,000 | $67,698,000 | $65,931,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,866,000 | 2,537,000 | 19,000 | 4,000 | 4,000 |
| Accounts payable and accrued liabilities | 2,667,000 | 2,867,000 | 2,301,000 | 2,098,000 | 2,146,000 |
| Accrued Expenses | 4,666,000 | 5,377,000 | 3,991,000 | 3,353,000 | 3,449,000 |
| TOTAL | $12,070,000 | $13,436,000 | $7,753,000 | $6,925,000 | $6,995,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,389,000 | 32,333,000 | 21,688,000 | 18,773,000 | 18,641,000 |
| Deferred Revenues | 2,871,000 | 2,655,000 | 1,442,000 | 1,470,000 | 1,396,000 |
| Other Non-Current Liabilities | 4,489,000 | 4,356,000 | 3,984,000 | 3,514,000 | 3,352,000 |
| TOTAL | $39,546,000 | $40,710,000 | $27,137,000 | $23,919,000 | $23,878,000 |
| Total Liabilities | $51,616,000 | $54,146,000 | $34,890,000 | $30,844,000 | $30,873,000 |
| Shareholders' Equity | |||||
| Common Shares | 440,000 | 439,000 | 439,000 | 438,000 | 438,000 |
| Retained earnings | 37,528,000 | 35,431,000 | 33,876,000 | 32,076,000 | 30,350,000 |
| Other shareholders' equity | -2,343,000 | -2,329,000 | -2,654,000 | -2,630,000 | -2,562,000 |
| TOTAL | $40,956,000 | $40,793,000 | $38,710,000 | $36,854,000 | $35,058,000 |
| Total Liabilities And Equity | $92,572,000 | $94,939,000 | $73,600,000 | $67,698,000 | $65,931,000 |